The promotion meeting for the selection of drug quality supervision in Jizhi

On August 30, the State Drug Administration organized the promotion meeting of the selection of drug quality supervision in the collection, summarized the preliminary work, exchanged supervision experience, analyzed the safety situation, and re -emphasized, mobilized, and deployed the selection of drug quality supervision. Essence Huang Guo, a member of the Party Group and Deputy Director of the State Drug Administration, attended the meeting and delivered a speech.

The meeting pointed out that the promotion of the implementation of centralized drugs and procurement is a major decision to effectively ensure the health and life safety of the people in the party and the government. It has played an important role in reducing drug prices, enhancing the well -being of people's livelihood, and promoting the reform of the three medical linkage. In the context of the normalization and institutionalization of drug concentrated band procurement work, the drug regulatory authorities at all levels should further improve the political standing, fully understand the importance of strengthening the selection of drug supervision, find the hidden dangers and weak links, strengthen the risk to strengthen the risk Prevention and control and hidden dangers, keep the bottom line of quality and safety, serve the overall situation and the overall medical reform work.

Huang Guo analyzed the quality and safety situation of selected medicines in the current collection and deployed the next step. The first is to focus on compacting the responsibility of the enterprise. Through policy promotion and regulatory training, strengthen the legal awareness, quality, and compliance awareness of the personnel of key positions in the enterprise; through full coverage of supervision and inspection and product random inspection, urge enterprises The full life cycle management, implement the full process of traceability management responsibilities. The second is to establish and improve supervision accounts. Implement the "one enterprise, one policy, one product, one file" for the selected drugs, adhere to the problem orientation, realize the sharing of supervision information, and improve the supervision of supervision and effectiveness with informationization. The third is to strive to form a joint supervision. The use of various regulatory methods, fully dispatch the supervision resources of each level, improve cross -department collaboration mechanisms, timely identify and control risks, and form a working pattern of combining joint management.

Huang Guo emphasized that the pharmaceutical regulatory authorities should take the courage to take responsibility, perform their duties, do their duties, take care of their duties, strengthen risk investigation and disposal in the collection of drug supervision. Twenty victories were held.

The meeting was held in a video. At the meeting, the responsible comrades of the drug regulatory departments in Jiangsu, Zhejiang, Shandong, Guangdong, Sichuan and other places gave speeches. The head of the Drug Supervision Department of the State Drug Administration, the person in charge of the inspection center, and the responsible comrades of the relevant office attended the meeting at the main venue. The person in charge of the institution attended the meeting.

- END -